Mark Deurinck

416 total citations
9 papers, 214 citations indexed

About

Mark Deurinck is a scholar working on Cardiology and Cardiovascular Medicine, Small Animals and Molecular Biology. According to data from OpenAlex, Mark Deurinck has authored 9 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Small Animals and 2 papers in Molecular Biology. Recurrent topics in Mark Deurinck's work include Sodium Intake and Health (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Animal testing and alternatives (2 papers). Mark Deurinck is often cited by papers focused on Sodium Intake and Health (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Animal testing and alternatives (2 papers). Mark Deurinck collaborates with scholars based in Switzerland, United States and France. Mark Deurinck's co-authors include Jonathan P. Mochel, Jérôme M. Giraudel, Mathieu Peyrou, Martin Fink, Meindert Danhof, Willi Suter, Martin Traebert, Haisong Ju, Bérengère Dumotier and Derek J. Leishman and has published in prestigious journals such as Pharmacology & Therapeutics, Toxicological Sciences and Alzheimer s & Dementia.

In The Last Decade

Mark Deurinck

8 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Deurinck Switzerland 6 96 82 38 24 24 9 214
John K. Finkle United States 7 235 2.4× 71 0.9× 14 0.4× 9 0.4× 5 0.2× 14 338
Maxim Soloviev United States 8 86 0.9× 96 1.2× 8 0.2× 14 0.6× 19 0.8× 13 270
Ujala Srivastava United States 10 284 3.0× 125 1.5× 36 0.9× 19 0.8× 16 436
Matthew R. Deshotels United States 6 100 1.0× 61 0.7× 16 0.4× 38 1.6× 11 315
Changcong Cui China 9 218 2.3× 183 2.2× 9 0.2× 2 0.1× 14 0.6× 29 320
Ken Matsuo Japan 8 129 1.3× 116 1.4× 70 1.8× 3 0.1× 12 0.5× 15 357
Toby P. Thomas United States 7 120 1.3× 107 1.3× 19 0.5× 1 0.0× 13 0.5× 7 217
Goutham Vasam Canada 10 43 0.4× 157 1.9× 38 1.0× 16 0.7× 20 272
Mingmei Xiong China 11 48 0.5× 123 1.5× 28 0.7× 9 0.4× 27 324

Countries citing papers authored by Mark Deurinck

Since Specialization
Citations

This map shows the geographic impact of Mark Deurinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Deurinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Deurinck more than expected).

Fields of papers citing papers by Mark Deurinck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Deurinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Deurinck. The network helps show where Mark Deurinck may publish in the future.

Co-authorship network of co-authors of Mark Deurinck

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Deurinck. A scholar is included among the top collaborators of Mark Deurinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Deurinck. Mark Deurinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Himmel, Herbert M., Annie Delaunois, Mark Deurinck, et al.. (2019). Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison. Journal of Pharmacological and Toxicological Methods. 99. 106571–106571. 5 indexed citations
2.
Hannesdóttir, Kristín, Oleksandr Sverdlov, Jelena Curcic, et al.. (2018). P4‐339: THE MEDIA STUDY: A NOVEL METHOD FOR EVALUATING DIGITAL ENDPOINTS IN ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 14(7S_Part_30).
3.
Himmel, Herbert M., Cara Heers, Christoph van Amsterdam, et al.. (2018). Inter-company reproducibility of Irwin/FOB CNS safety assessment following reference drugs chlorpromazine and amphetamine. Journal of Pharmacological and Toxicological Methods. 93. 109–110. 3 indexed citations
4.
Guntermann, Christine, Alessandro Piaia, Diethilde Theil, et al.. (2017). Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations. JCI Insight. 2(5). e91127–e91127. 41 indexed citations
5.
Spence, Stan, Mark Deurinck, Haisong Ju, et al.. (2016). Histone Deacetylase Inhibitors Prolong Cardiac Repolarization through Transcriptional Mechanisms. Toxicological Sciences. 153(1). 39–54. 24 indexed citations
6.
Mochel, Jonathan P., Martin Fink, Mathieu Peyrou, et al.. (2014). Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs. Chronobiology International. 31(5). 715–730. 36 indexed citations
7.
Ewart, Lorna, Mike Aylott, Mark Deurinck, et al.. (2014). The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative. Toxicological Sciences. 142(2). 427–435. 53 indexed citations
8.
Mochel, Jonathan P., Martin Fink, Mathieu Peyrou, et al.. (2013). Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology. Chronobiology International. 30(9). 1144–1159. 32 indexed citations
9.
Dumotier, Bérengère, et al.. (2008). Relevance of in vitro SCREENIT results for drug-induced QT interval prolongation in vivo: A database review and analysis. Pharmacology & Therapeutics. 119(2). 152–159. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John K. Finkle Breakdown of academic impact, for papers by Maxim Soloviev Breakdown of academic impact, for papers by Ujala Srivastava Breakdown of academic impact, for papers by Matthew R. Deshotels Breakdown of academic impact, for papers by Changcong Cui Breakdown of academic impact, for papers by Ken Matsuo Breakdown of academic impact, for papers by Toby P. Thomas Breakdown of academic impact, for papers by Goutham Vasam Breakdown of academic impact, for papers by Mingmei Xiong
Rankless by CCL
2026